Schedule 13D ownership disclosure

Accelerate Diagnostics, Inc

Security class unavailable · CUSIP: 00430H102

Event date: 2021-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
18,409,240
Percent of class
26.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-146014
Form type
SC 13D/A
Filer
Accelerate Diagnostics, Inc
CIK
CIK 727207
Filed
Dec 03, 2021
Reporting period
Nov 29, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub